18 and older, any sex, with Posttraumatic Stress Disorder or Tonic Immobility Response. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Posttraumatic Stress Disorder SymptomsPrimary· up to 1 month
PTSD symptoms measured using the posttraumatic stress checklist for DSM-5 (PCL-5). The PCL-5 is a 20-item scale with values ranging from 0 to 4 for each item. Items are totaled for a total score ranging 0 to 80, with lower values indicating better outcomes.
Group
Value
95% CI
Tonic Immobility Psychoeducation (TIP)
30.41
± 18.23
Health Education Training (HET)
31.93
± 18.33
GuiltPrimary· post-intervention, on Day 1
Feelings of guilt as measured using the state shame-guilt scale, 8-item (SSGS-8); Value range = 5 to 20 with lower values indicating better outcomes.
Group
Value
95% CI
Tonic Immobility Psychoeducation (TIP)
6.6
± 2.94
Health Education Training (HET)
6.85
± 3.86
ShamePrimary· post-intervention, on Day 1
Feelings of shame as measured using the state shame-guilt scale, 8-item (SSGS-8); Value range = 5 to 20 with lower values indicating better outcomes.
Group
Value
95% CI
Tonic Immobility Psychoeducation (TIP)
6.80
± 2.80
Health Education Training (HET)
6.7
± 3.76
Sponsor's own description
A randomized controlled trial is planned to evaluate a brief, web-based intervention intended to educate about tonic immobility (TI) within a sample of those who experienced TI in the context of a traumatic event.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Florida State University
Last refreshed: 23 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05113277.